CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition Director disposed of 58,857 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 166,667 shares (grant or award)
- 4 Grant or award Director acquired 834,334 shares (grant or award)
- 4 Grant or award Director acquired 1,500,000 shares (grant or award)
- 4 Open-market buy Director bought 24,670 shares at $13.63 ($336,252)
- 4 Open-market buy Director bought 30,000 shares at $13.15 ($394,500)
- 4 Open-market buy Chief Medical Officer bought 4,000 shares at $13.20 ($52,800)
- 4 Open-market buy Director bought 30,000 shares at $13.20 ($396,000)
Page 4 of 15 · 290 filings